We define in molar units: P, the concentration of unbound free OppA protein; L, the concentration of unbound free labeled BK-SR101 peptide; U, the concentration of unbound free unlabeled competitor; PL, the concentration of the labeled OppA-(BK-SR101) complex; PU, the concentration of the unlabeled OppA-competitor complex; P T = P + PU + PL, the total OppA protein concentration; L T = L + PL, the total labeled BK-SR101 peptide concentration; U T = U + PU, the total unlabeled competitor concentration; K L , the dissociation constant for the labeled OppA-(BK-SR101) complex; K U , the dissociation constant for the unlabeled OppA-competitor complex. As previously described by Wang (FEBS Lett. 1995, 360:111) and Roehrl et al. (Biochemistry 2004, 43:16056) , an analytical solution can be written for the fraction of labeled BK-SR101 peptide that is bound to the OppA protein (F PL ): For our assay conditions at each pH and temperature, we experimentally determined the minimum anisotropy, r min , of the labeled BK-SR101 alone. We also determined the maximum anisotropy, r max , of the labeled OppA-(BK-SR101) complex without any competitor present. Therefore, we can write a standard saturation binding equation for the total anisotropy (r):
• By rearranging this equation, anisotropy from the competitor dose-response experiments was converted to the fraction bound labeled BK-SR101:
We used the Matlab non-linear least squares fitting function lsqcurvefit to fit our competition dose-response data and determine the unlabeled competitor dissociation constant (referred to as the "fitted K U "). We compared the Trust Region Reflective and LevenbergMarquardt optimization algorithms. Both algorithms produced similar results, but the Trust Region Reflective converged more robustly, and therefore we report results using the default Trust Region Reflective algorithm in Table I and Table III in the main text. Matlab code is included at the end of the Supplemental Information. Dose response data for each replicate were fitted ( Figures S4 and S5) , and then the fitted K U values were averaged and reported in in Table I and  Table III in the main text. We achieve greater accuracy in determining K U by directly fitting dose-response data to the complete competition binding model, especially when the Cheng-Prusoff equation is not valid. However, we expect that there will still be limitations to this fitting approach determined by experimental assay parameters. In particular, we expect that when the true competitor affinity is very high beyond a certain threshold, the fitted K U values will become indistinguishable. In order to determine this threshold (effectively the lower limit of fitted K U estimation), we simulated anisotropy dose-response data in which we varied the theoretical K U value for the unlabeled competitor. We then fit the simulated data and determined at what simulated K U values the fitted K U values no longer reliably estimate the simulated K U values. Across different pH and temperature, the OppA-(BK-SR101) binding affinity was approximately K L = 10 µM, which we set as an experimental constant. We therefore explored K U values ±3 log 10 units around K L by simulating data for K U = 10 -8 M to 10 -2 M at 0.1 log 10 unit increments. We also set experimental assay parameters for total OppA protein concentration P T = 11.25 µM, total labeled BK-SR101 peptide concentration L T = 0.75 µM, and the approximate competitor peptide concentration range U T = 10 -8 M to 10 -2 M. The standard deviation for our replicate anisotropy measurements was approximately 2% of the mean, and for a normal distribution, the full width at half maximum (FWHM) is 2ꞏ(2ln2) 1/2 times the standard deviation. Therefore to achieve an approximate 5% FWHM, we added normally distributed random numbers scaled to a maximum percent error range of -10% to 10% to the simulated data. Using these experimental parameters, for each theoretical K U value we simulated 1000 dose-response data sets and then fitted the simulated data to determine the fitted K U value ( Figure S6 ). We then analyzed the relationship between the fitted K U versus the simulated K U ( Figure S6 ). Below a simulated K U value of 10 -7 M, fitting became more error prone. We then estimated the probability that the fitted K U was within an N-fold range of the simulated K U (Figure S6 ). At a simulated K U value of 10 -7 M, there was only a 50% probability that the fitted K U would be within 2-fold of the simulated K U value. Therefore, we made the conservative decision that for any experimental data that results in a fitted K U ≤ 10 -7 M, we consider it a "high affinity" competitor and we report K U ≤ 10 -7 M in Table III Figure S6 . Determining the limit of K U estimation under experimental conditions. (A) An example of 1 simulated dose-response data set: simulated K U = 10.0 µM; fitted K U = 9.6 ± 3.2 µM (mean ± 95% confidence interval). (B) The fitted K U values from 1000 simulated data sets is plotted against the simulated K U value. Below a simulated K U value of 0.1 µM, fitting and estimation cannot distinguish between K U values for high affinity competitors. (C) The 1000 simulated data sets were analyzed to estimate the probability that the fitted K U valued would fall within N-fold of the true simulated K U value. 1.E-13
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SUPPORTING METHODS
AppA Plasmid Construct The Bacillus subtilis oligopeptide-binding protein (AppA) amino acid sequence is from subspecies subtilis strain 168 (GenBank accession AAA62358.1). Similar to OppA, the AppA N-terminal signal peptide for palmitoylation and surface tethering was removed ( Figure S11 ) and the nucleotide sequence was synthesized as a gBlock. The AppA gBlock was cloned into a pRSETB vector by Gibson Assembly for bacterial expression and purification ( Figure S11 ).
AppA Expression and Purification
The Bacillus subtilis AppA was expressed and purified similar to OppA from Lactococcus lactis, except that large AIM cultures (250 mL) were grown at 37°C overnight (~16 hrs), which gave us the highest BsAppA expression levels. Concentration of purified AppA was determined by absorbance at 280 nm using an extinction coefficient of 97860 M -1 *cm -1 calculated using the Northwestern University Peptide Properties Calculator.
AppA Fluorescence Anisotropy Assay Preliminary direct dose response binding for AppA was performed the same as the direct dose response binding for OppA. However, the AppA anisotropy assays were performed at 37C in pH 7 Assay Buffer. SR101-bradykinin was selected for all following AppA anisotropy assays because of its higher affinity for AppA compared to bradykinin-SR101 ( Figure S11 ). Follow up direct dose response assays were performed at varying temperatures by combining 100 L of 1.5 M SR101-RPPGFSPFR and 50 L purified AppA to wells in a 96-well non-binding microplate ( Figure S11 ). Final concentrations of AppA varied from 0.01 to 150 M.
Competition dose response binding was performed similar to OppA, except a mixture of 1 M SR101-bradykinin and 25 M AppA was prepared, and 150 L of the mixture was added to each well in a 96-well non-binding microplate. A higher concentration of AppA was used due to its lower affinity for the dye-labeled peptide (Table S1) , however, this assay should be further optimized to improve the dynamic range ( Figure S11 ).
